UNIVERSITY OF SOUTHERN CALIFORNIA

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1880-01-01

Employees: 10K

Market Cap: -

Website: http://startusc.com

Clinical Trials

Exercise Intervention in Targeting Adiposity and Inflammation With Movement to Improve Prognosis in Breast Cancer

Not Applicable

Withdrawn

Conditions: Central Obesity
Stage IB Breast Cancer
Stage IIIB Breast Cancer
Cancer Survivor
Progesterone Receptor Positive
Postmenopausal
Stage IA Breast Cancer
Stage IIA Breast Cancer
Stage IIB Breast Cancer
Stage I Breast Cancer

Interventions: Behavioral: Exercise Intervention
Other: Laboratory Biomarker Analysis
Other: Informational Intervention
Other: Quality-of-Life Assessment
Other: Questionnaire Administration

First Posted Date: 2017-03-27

Last Posted Date: 2019-10-24

Lead Sponsor: University of Southern California

Registration Number: NCT03091842

Locations: 🇺🇸
USC / Norris Comprehensive Cancer Center, Los Angeles, California, United States

Antibiotics to Decrease Post ERCP Cholangitis

Phase 4

Recruiting

Conditions: Cholangitis

Interventions: Drug: Ceftriaxone
Drug: Levofloxacin

First Posted Date: 2017-03-22

Last Posted Date: 2023-03-06

Lead Sponsor: University of Southern California

Target Recruit Count: 200

Registration Number: NCT03087656

Locations: 🇺🇸
Los Angeles County Hospital, Los Angeles, California, United States

Movement-based Infant Intervention

Not Applicable

Completed

Conditions: Infant,Premature
Infant, Very Low Birth Weight
Infant Conditions
Infant, Small for Gestational Age
Infant Development

Interventions: Behavioral: Movement Intervention

First Posted Date: 2017-03-17

Last Posted Date: 2022-04-05

Lead Sponsor: University of Southern California

Target Recruit Count: 12

Registration Number: NCT03082313

Locations: 🇺🇸
Infant Neuromotor Control Laboratory, Los Angeles, California, United States

Targeted Enteral Nutrient Delivery: A Prospective Randomized Study

Not Applicable

Completed

Conditions: Diabetes Mellitus, Type 2

Interventions: Dietary Supplement: Whey Protein in Enteric Coating
Dietary Supplement: Pea Protein in Enteric Coating
Dietary Supplement: Sucrose in Enteric Coating
Dietary Supplement: Non coated Sucrose plus Whole Milk
Dietary Supplement: Sucrose plus Whole Milk Powder in Enteric Coating
Dietary Supplement: Sucrose with Separate Enteric Coating Materials
Dietary Supplement: Whey Protein with Separate Enteric Coating Materials
Dietary Supplement: Pea Protein with Separate Enteric Coating Materials

First Posted Date: 2017-02-27

Last Posted Date: 2019-06-18

Lead Sponsor: University of Southern California

Target Recruit Count: 19

Registration Number: NCT03064347

Locations: 🇺🇸
USC Diabetes & Obesity Research Institute (DORI), Los Angeles, California, United States

Clinical Model in Evaluating Clinical, Psychosocial, and Health Economic Factors in Adolescent and Young Adult Patients With Cancer

Terminated

Conditions: Malignant Neoplasm

Interventions: Other: Quality-of-Life Assessment
Other: Questionnaire Administration

First Posted Date: 2017-02-20

Last Posted Date: 2022-08-10

Lead Sponsor: University of Southern California

Target Recruit Count: 76

Registration Number: NCT03057639

Locations: 🇺🇸
USC / Norris Comprehensive Cancer Center, Los Angeles, California, United States

Recombinant EphB4-HSA Fusion Protein and Pembrolizumab, MK-3475

Phase 2

Active, not recruiting

Conditions: BRAF Gene Mutation
Head and Neck Squamous Cell Carcinoma
Recurrent Head and Neck Carcinoma
Recurrent Non-Small Cell Lung Carcinoma
Stage IIIB Non-Small Cell Lung Cancer
EGFR Gene Mutation
ROS1 Gene Mutation
Stage IIIA Non-Small Cell Lung Cancer
Stage IV Non-Small Cell Lung Cancer
ALK Gene Mutation

Interventions: Other: Laboratory Biomarker Analysis
Biological: Pembrolizumab
Biological: Recombinant EphB4-HSA Fusion Protein

First Posted Date: 2017-02-10

Last Posted Date: 2024-03-18

Lead Sponsor: University of Southern California

Target Recruit Count: 42

Registration Number: NCT03049618

Locations: 🇺🇸
USC / Norris Comprehensive Cancer Center, Los Angeles, California, United States

Exercise and Diet Intervention in Promoting Weight Loss in Obese Patients With Stage I Endometrial Cancer

Not Applicable

Withdrawn

Conditions: Estrogen Receptor Positive
Progesterone Receptor Positive
Stage IB Uterine Corpus Cancer
Obesity
Stage I Uterine Corpus Cancer
Stage IA Uterine Corpus Cancer

Interventions: Dietary Supplement: Dietary Intervention
Behavioral: Exercise Intervention
Other: Laboratory Biomarker Analysis
Other: Quality-of-Life Assessment